Disclosures for "Evaluating the Safety, Tolerability, and Pharmacokinetics of QRL-101 in Two Phase 1 Studies: QRL-101-01 in Healthy Adults and QRL-101-02 in Adults with ALS"
-
Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
-
Dr. Boggs has received personal compensation for serving as an employee of Quralis Corp. Dr. Boggs has stock in Quralis Corp. Dr. Boggs has stock in Eli Lilly and Company.
-
Dr. Ganti has nothing to disclose.
-
Dr. Hinckley has received personal compensation for serving as an employee of QurAlis Corporation. An immediate family member of Dr. Hinckley has received personal compensation for serving as an employee of Biogen. An immediate family member of Dr. Hinckley has stock in Biogen.
-
Ms. Johnson has received personal compensation for serving as an employee of QurAlis. Ms. Johnson has stock in QurAlis.
-
Dr. Polzer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for QurAlis. Dr. Polzer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarkana Pharma, Inc. Dr. Polzer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ocellaris Pharma, Inc. Dr. Polzer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Esperas Pharma, Inc..
-
Ms. Rubino has received personal compensation for serving as an employee of QurAlis. Ms. Rubino has stock in Praxis Precision Medicines.
-
Miss Salmon has received personal compensation for serving as an employee of QurAlis Corporation. Miss Salmon has stock in QurAlis Corporation.
-
Dr. Elbaum has received personal compensation for serving as an employee of QurAlis. Dr. Elbaum has stock in QurAlis. Dr. Elbaum has stock in Amylyx. Dr. Elbaum has stock in Amgen. Dr. Elbaum has stock in Pfizer.